Browse > Article
http://dx.doi.org/10.22722/KJPM.2020.28.2.99

Fibromyalgia from the Psychiatric Perspective  

Lee, Yunna (Department of Psychiatry, Kosin University Gospel Hospital)
Lee, Sang-Shin (Department of Psychiatry, Kosin University Gospel Hospital)
Kim, Hyunseuk (Department of Child and Adolescent Psychiatry, National Center for Mental Health)
Kim, Hochan (Department of Psychiatry, Kosin University Gospel Hospital)
Publication Information
Korean Journal of Psychosomatic Medicine / v.28, no.2, 2020 , pp. 99-107 More about this Journal
Abstract
Fibromyalgia is a disorder characterized by the core symptom of chronic widespread pain, along with fatigue, sleep disturbances, mood changes, and cognitive difficulties. The etiology of fibromyalgia involves a combination of biological factors, such as genetic vulnerability, alterations in pain processing and stress response system ; psychological factors, such as anxiety, depression, anger, and perceived stress ; environmental factors, such as infections, febrile diseases, and trauma. Central sensitization, which is amplified in the process of sensory stimulation, has been emphasized as a key etiological factor, as supported by enhanced wind-up, delayed aftersensation, decreased nociceptive flexion reflex threshold and functional imaging studies. Several guidelines recommend that a multimodal approach be used to treat fibromyalgia, including both pharmacological and non-pharmacological treatments, tailored to each individual, and that clinicians should provide an intellectual framework through sufficient education and emphasis on the importance of self-management. The prevalence of mood disorders, anxiety disorders, and other psychiatric problems is 7-9 times higher in patients with fibromyalgia than in the general population ; moreover, the association between fibromyalgia and certain psychopathologies or sleep problems has also been suggested. Since psychiatric problems, with shared vulnerabilities and risk factors, interact with fibromyalgia bidirectionally and also affect the disease course, an integrated management approach is needed to determine the risk of comorbidities.
Keywords
Fibromyalgia; Pathophysiological mechanism; Psychological factors; Diagnostic criteria; Treatment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee HJ, Choi E, Nahm FS, Choi SS, Kim YH, Moon JY, Kim SH, Cho CW, Lee PB. Prevalence of fibromyalgia in fourteen Korean tertiary care university hospital pain clinics. J Pain Res 2018;11:2417-2423.   DOI
2 Hauser W, Schild S, Kosseva M, Hayo S, von Wilmowski H, Alten R, Langhorst J, Hofmann W, Maus J, Glaesmer H. Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome. Schmerz 2010;24: 226-235.   DOI
3 Kudlow PA, Rosenblat JD, Weissman CR, Cha DS, Kakar R, McIntyre RS, Sharma V. Prevalence of fibromyalgia and co-morbid bipolar disorder: a systematic review and meta-analysis. J Affect Disord 2015;188:134-142.   DOI
4 Crofford LJ. Chapter 52-Fibromyalgia. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, editors. Kelley and Firestein's Textbook of Rheumatology (Tenth Edition): Elsevier;2017. p.768-783.e763.
5 대한류마티스학회. 류마티스학. 2판. ed. 서울: 범문에듀케이션; 2018.
6 Mogil JS. Pain genetics: past, present and future. Trends Genet 2012;28:258-266.   DOI
7 Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr. Family study of fibromyalgia. Arthritis Rheum 2004;50:944-952.   DOI
8 Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I, Olson JM, Iyengar SK. The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum 2013;65: 1122-1128.   DOI
9 D'Agnelli S, Arendt-Nielsen L, Gerra MC, Zatorri K, Boggiani L, Baciarello M, Bignami E. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Mol Pain 2019;15: 1744806918819944.
10 Uceyler N, Sommer C, Walitt B, Hauser W. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev 2013:Cd010782.
11 Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain 2009;145: 69-81.   DOI
12 Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, crohn's disease, and other chronic pain disorders. Pharmacotherapy 2018;38:382-389.   DOI
13 Gaskell H, Moore RA, Derry S, Stannard C. Oxycodone for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2016;9:Cd012329.
14 Sommer C, Hauser W, Alten R, Petzke F, Spath M, Tolle T, Uceyler N, Winkelmann A, Winter E, Bar KJ. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. Schmerz 2012;26:297-310.   DOI
15 Hauser W, Walitt B, Fitzcharles MA, Sommer C. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther 2014;16:201.   DOI
16 Bernardy K, Klose P, Welsch P, Hauser W. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome-a systematic review and meta-analysis of randomized controlled trials. Eur J Pain 2018;22:242-260.   DOI
17 Haugmark T, Hagen KB, Smedslund G, Zangi HA. Mindfulness- and acceptance-based interventions for patients with fibromyalgia-a systematic review and meta-analyses. PLoS One 2019;14:e0221897.   DOI
18 Ciampi de Andrade D, Maschietto M, Galhardoni R, Gouveia G, Chile T, Victorino Krepischi AC, Dale CS, Brunoni AR, Parravano DC, Cueva Moscoso AS, Raicher I, Kaziyama HHS, Teixeira MJ, Brentani HP. Epigenetics insights into chronic pain: DNA hypomethylation in fibromyalgia-a controlled pilot-study. Pain 2017;158:1473-1480.   DOI
19 Park DJ, Kim SH, Nah SS, Lee JH, Kim SK, Lee YA, Hong SJ, Kim HS, Lee HS, Kim HA, Joung CI, Kim SH, Lee SS. Association between brain-derived neurotrophic factor gene polymorphisms and fibromyalgia in a Korean population: a multicenter study. Arthritis Res Ther 2018;20:220.   DOI
20 Menzies V, Lyon DE, Archer KJ, Zhou Q, Brumelle J, Jones KH, Gao G, York TP, Jackson-Cook C. Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nurs Res Pract 2013;2013:795784.   DOI
21 Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152:S2-15.   DOI
22 Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001;91:165-175.   DOI
23 Staud R, Weyl EE, Riley JL 3rd, Fillingim RB. Slow temporal summation of pain for assessment of central pain sensitivity and clinical pain of fibromyalgia patients. PLoS One 2014; 9:e89086.   DOI
24 Hachisuka J, Omori Y, Chiang MC, Gold MS, Koerber HR, Ross SE. Wind-up in lamina I spinoparabrachial neurons: a role for reverberatory circuits. Pain 2018;159:1484-1493.   DOI
25 Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-1343.   DOI
26 Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, Dayer P, Vischer TL. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003;48:1420-1429.   DOI
27 Hauser W, Urrutia G, Tort S, Uceyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 2013:Cd010292.
28 Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007;27:10000-10006.   DOI
29 Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 2009;10:663-672.   DOI
30 Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, Clauw DJ. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009;60:3146-3152.   DOI
31 Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364-378.
32 Lopez-Sola M, Woo CW, Pujol J, Deus J, Harrison BJ, Monfort J, Wager TD. Towards a neurophysiological signature for fibromyalgia. Pain 2017;158:34-47.   DOI
33 Zamuner AR, Barbic F, Dipaola F, Bulgheroni M, Diana A, Atzeni F, Marchi A, Sarzi-Puttini P, Porta A, Furlan R. Relationship between sympathetic activity and pain intensity in fibromyalgia. Clin Exp Rheumatol 2015;33:S53-57.
34 Uceyler N, Hauser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord 2011;12:245.   DOI
35 Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009;10:23-36.   DOI
36 Martinez-Martinez LA, Mora T, Vargas A, Fuentes-Iniestra M, Martinez-Lavin M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol 2014;20:146-150.   DOI
37 Choy EH. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol 2015;11:513-520.   DOI
38 Eisenlohr-Moul TA, Crofford LJ, Howard TW, Yepes JF, Carlson CR, de Leeuw R. Parasympathetic reactivity in fibromyalgia and temporomandibular disorder: associations with sleep problems, symptom severity, and functional impairment. J Pain 2015;16:247-257.   DOI
39 Eller-Smith OC, Nicol AL, Christianson JA. Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front Cell Neurosci 2018;12:35.
40 Galvez-Sanchez CM, Duschek S, Reyes Del Paso GA. Psychological impact of fibromyalgia: current perspectives. Psychol Res Behav Manag 2019;12:117-127.   DOI
41 Cetin B, Gulec H, Toktas HE, Ulutas O, Yilmaz SG, Isbir T. Objective measures of sleep in fibromyalgia syndrome: Relationship to clinical, psychiatric, and immunological variables. Psychiatry Res 2018;263:125-129.   DOI
42 Loge-Hagen JS, Sæle A, Juhl C, Bech P, Stenager E, Mellentin AI. Prevalence of depressive disorder among patients with fibromyalgia: systematic review and meta-analysis. J Affect Disord 2019;245:1098-1105.   DOI
43 Palagini L, Carmassi C, Conversano C, Gesi C, Bazzichi L, Giacomelli C, Dell'Osso L. Transdiagnostic factors across fibromyalgia and mental disorders: sleep disturbances may play a key role. A clinical review. Clin Exp Rheumatol 2016;34: S140-144.
44 Martinez-Lavin M. Fibromyalgia and small fiber neuropathy: the plot thickens! Clin Rheumatol 2018;37:3167-3171.   DOI
45 Kayhan F, Kucuk A, Satan Y, Ilgun E, Arslan S, Ilik F. Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia. Neuropsychiatr Dis Treat 2016;12:349-355.   DOI
46 Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. PLoS One 2015;10:e0138024.   DOI
47 Attademo L, Bernardini F. Prevalence of personality disorders in patients with fibromyalgia: a brief review. Prim Health Care Res Dev 2018;19:523-528.   DOI
48 Cunningham NR, Tran ST, Lynch-Jordan AM, Ting TV, Sil S, Strotman D, Noll JG, Powers SW, Arnold LM, Kashikar-Zuck S. Psychiatric disorders in young adults diagnosed with juvenile fibromyalgia in adolescence. J Rheumatol 2015; 42:2427-2433.   DOI
49 Lange M, Petermann F. Influence of depression on fibromyalgia: a systematic review. Schmerz 2010;24:326-333.   DOI
50 Novo R, Gonzalez B, Peres R, Aguiar P. A meta-analysis of studies with the minnesota multiphasic personality inventory in fibromyalgia patients. Personality and Individual Differences 2017;116:96-108.   DOI
51 Garcia-Fontanals A, Portell M, Garcia-Blanco S, Poca-Dias V, Garcia-Fructuoso F, Lopez-Ruiz M, Gutierrez-Rosado T, Goma IFM, Deus J. Vulnerability to psychopathology and dimensions of personality in patients with fibromyalgia. Clin J Pain 2017;33:991-997.   DOI
52 Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep 2016;20:25.   DOI
53 Vincent A, Whipple MO, Rhudy LM. Fibromyalgia flares: a qualitative analysis. Pain Med 2016;17:463-468.
54 Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The american college of rheumatology 1990 criteria for the classification of fibromyalgia. report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-172.   DOI
55 Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-610.   DOI
56 Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag 2013;18:119-126.   DOI
57 Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46:319-329.   DOI
58 Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38: 1113-1122.   DOI
59 Wolfe F, Hauser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med 2011;43:495-502.   DOI
60 Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, FluB E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017;76:318-328.   DOI
61 Thieme K, Mathys M, Turk DC. Evidenced-based guidelines on the treatment of fibromyalgia patients: are they consistent and if not, why not? have effective psychological treatments been overlooked? J Pain 2017;18:747-756.   DOI
62 Nuesch E, Hauser W, Bernardy K, Barth J, Juni P. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis 2013;72:955-962.   DOI
63 Hauser W, Wolfe F, Tolle T, Uceyler N, Sommer C. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 2012;26:297-307.   DOI
64 Kim C, Kim H, Kim J. Prevalence of chronic widespread pain and fibromyalgia syndrome: a Korean hospital-based study. Rheumatol Int 2012;32:3435-3442.   DOI
65 Clauw DJ. Fibromyalgia: a clinical review. Jama 2014;311:1547-1555.   DOI
66 Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013;17:356.   DOI
67 Hauser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B. Fibromyalgia. Nat Rev Dis Primers 2015;1:15022.   DOI